Nanocs dithio NHS functionalized polyethylene glycol (PEG-S-S-NHS) is a reducing reagent cleavable and amine (-NH2) reactive PEG derivative that can be used to modify protein, peptide or any other material surfaces with their available amino groups. Dithiol-NHS esters react with primary amine groups at pH 7~8.5 to form stable amide bonds, meanwhile, disulfide bond can be cleaved by DTT, TCEP and other disulfide bond reducing reagents.
Spécifications
Spécifications et pureté
MW 2000 Da
Conditions de stockage de stockage
Store at -20°C,Argon charged
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Données avancées
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
Item-specific, tested protocols: Not specified for this item; refer to CoA/Spec Sheet. Below are example research workflows appropriate for NHS/thiol PEG linkers (general guidance only).
Example A: Amine coupling in buffered aqueous media
Prepare 10–50 mM stock in anhydrous DMSO under argon immediately before use.
Buffer the amine-bearing substrate in 50 mM bicarbonate, pH 8.3 (pre-degassed), with 1 mM EDTA.
Add the stock dropwise to achieve 5–20 mol% excess over accessible amines; mix gently at 4–25°C for 30–90 min.
Quench residual NHS with 20 mM ethanolamine (10–15 min), then purify (SEC/dialysis/spin columns).
Example B: Thiol coupling to maleimide-functional target
Ensure thiols are reduced (add 0.5–1 mM TCEP for 10–20 min, then remove excess if necessary).
Exchange into 50 mM phosphate, pH 6.8–7.0, 1 mM EDTA, oxygen minimized.
Combine with maleimide-bearing partner at 1.0–1.5 equiv per thiol; incubate 15–60 min at RT.
Cap unreacted maleimide with excess cysteine if needed; purify and analyze (SEC, Ellman’s assay).
Example C: Gold surface attachment (materials)
Clean Au substrate; immerse in 0.1–1 mM solution of the PEG dithiol in ethanol/ACN (oxygen-scrubbed) for 2–12 h.
Rinse, dry under nitrogen; characterize monolayer by contact angle and XPS.
Always validate on small scale and tailor to your substrate.
Biological Roles
Item-specific biological roles: Not applicable; this is a synthetic research reagent. No biological role data are specified for this item.
General context (informational, not a medical claim):
Poly(ethylene glycol) (PEG) is biologically inert and highly hydrophilic, often used to reduce protein adsorption and minimize nonspecific interactions on surfaces ("stealth" behavior). It lacks intrinsic bioactivity but can modulate the biological interface of conjugated molecules.
NHS ester reactivity toward primary amines is exploited in bioconjugation to proteins, peptides, and amine-functionalized biomaterials, forming stable amide bonds under mild, near-physiological conditions.
Thiol groups participate in biologically relevant chemistries, including disulfide formation/exchange and selective coupling to maleimide-bearing probes. Maintaining thiols in the reduced state commonly uses mild reducing agents (e.g., TCEP) and metal chelators (EDTA) to prevent oxidative dimerization.
PEGylation can influence hydrodynamic size, solubility, and colloidal stability of biomolecule conjugates, which is valuable for in vitro assays, sensor construction, and materials science experiments.
Note: This product is provided strictly for research use only and is not intended for diagnostic, therapeutic, or other clinical applications.
Buffer Applications
Item-specific buffer recommendations: Not specified for this item; refer to CoA/Spec Sheet. The following are general guidelines for NHS/thiol PEG conjugations.
Buffers for NHS–amine coupling (general):
Preferred: 50–100 mM sodium bicarbonate/carbonate, pH 8.3–8.6; or 50 mM phosphate/PBS, pH 7.2–7.8 when lower pH is needed to protect sensitive biomolecules (with somewhat slower kinetics).
Avoid: primary amine-containing buffers (Tris, glycine, ammonium bicarbonate) and high concentrations of competing nucleophiles.
Additives: 1–5 mM EDTA to chelate metals; 0.01–0.05% nonionic surfactant (e.g., Tween-20) only if necessary for solubilization and if it does not interfere with the system.
Buffers for thiol chemistry (general):
Maleimide coupling: pH 6.5–7.2 (phosphate or HEPES). Keep oxygen exposure minimal; include EDTA. Avoid high pH that can hydrolyze maleimide.
Disulfide exchange: pH 7.5–8.5 with a defined redox buffer (e.g., reduced/oxidized glutathione) if controlled exchange is desired.
Maintaining reduced thiols: 0.5–1 mM TCEP freshly added; avoid DTT if downstream maleimide reactions are planned, as DTT can consume maleimides.
Preparation tips:
Dissolve reagent in minimal anhydrous DMSO/DMF, then add to the buffered solution right before use.
Pre-filter buffers (0.22 μm) and degas if thiol oxidation is a concern.
Work cold (4–10°C) to slow NHS hydrolysis when setup times are long.
Green Alternatives
While the reagent itself is defined by its PEG/NHS/thiol chemistry, greener choices can be made in solvent and process selection (general guidance):
Comparison of solvent choices (informational):
DMF (conventional): excellent performance for NHS esters; reproductive-tox classification; challenging waste stream. Consider minimizing volume and exposure.
DMSO (preferred where feasible): high polarity, low volatility, favorable toxicological profile; can replace DMF in many cases, particularly for short handling prior to aqueous dilution.
Acetonitrile: lower toxicity than DMF; may have limited PEG solubility at higher MW; good for certain surface couplings.
Aqueous buffers: the greenest option for NHS–amine coupling; prepare concentrated stock in minimal dry DMSO, then dilute into buffer immediately before use to reduce organic solvent use.
Emerging bio-based solvents: Cyrene (dihydrolevoglucosenone) and gamma-valerolactone may support some activated ester reactions; validate solubility and stability of the specific PEG reagent before adoption.
Process intensification and waste minimization:
Use micro- to milliliter-scale reactions with precise stoichiometry to limit excess reagent and hydrolysis byproducts.
Employ inert-atmosphere dispensing and single-use, pre-dried aliquots to extend shelf-life and reduce failed runs.
Select buffers without amine components to avoid side reactions and rework.
Trade-offs:
Lower-toxicity solvents may increase viscosity (DMSO) or reduce solubility (water/ACN) depending on PEG length; confirm kinetics and conversion against your target system.
Pharmaceutical Uses
Item-specific pharmacopeial status or GMP suitability: Not specified for this item; refer to CoA/Spec Sheet. Supplied for research use only.
General formulation/manufacturing context (non-clinical, informational):
PEG and PEG-derived linkers are widely used in process development for conjugation studies, surface passivation of devices, and creation of model PEGylated biomolecules. Their hydrophilicity can enhance solubility and reduce aggregation in research formulations.
NHS-functional PEG reagents are commonly evaluated during method development of protein conjugation workflows to optimize reaction pH, stoichiometry, and selectivity before any transfer to regulated materials.
Thiol functionality supports linkage to maleimide-bearing excipients or surfaces, and to noble-metal substrates (Au–S chemisorption) for sensor prototyping.
From a CMC perspective, critical quality attributes typically include: PEG molecular-weight distribution (Ð), functional group content (ester titer, thiol titer), residual solvents, hydrolysis/oxidation products, and endotoxin/bioburden if intended for device-contacting research. For this catalog item, such attributes are not specified here and should be obtained from the CoA.
Note: This reagent is not an API, not an excipient qualified to pharmacopeial monographs, and not for human or veterinary use.
Physical Properties
Item-specific physical data (BP, MP, density, exact solubility, logP, pKa, refractive index): Not specified for this item; refer to CoA/Spec Sheet.
General/literature characteristics for PEG-based NHS/thiol linkers (informational, not item-specific specifications):
Physical state: typically solid or viscous semi-solid depending on PEG molecular weight and substitution.
Hygroscopicity: PEG-based NHS esters are moisture-sensitive; NHS esters hydrolyze in water and under basic conditions.
Solubility: often freely soluble in polar aprotic solvents (anhydrous DMF, DMSO, acetonitrile) and variably soluble in aqueous buffers, with solubility increasing with PEG length. Thiol-bearing PEGs are usually miscible with water/organics due to PEG’s amphiphilicity.
Thermal behavior: PEG domains soften with increasing temperature (broad glass transition); NHS function decomposes on prolonged heating.
Odor: essentially odorless; thiol groups may impart faint mercaptan odor if exposed/oxidized.
Stability notes: thiols can oxidize to disulfides upon air exposure; NHS esters hydrolyze to the corresponding carboxylate and NHS. Inert atmosphere and desiccation are recommended.
Handling implications (general):
Prepare fresh anhydrous stock solutions immediately before use.
Avoid elevated temperatures during storage or extended reaction setup to minimize NHS hydrolysis and thiol oxidation.
Consider adding reducing agents (e.g., TCEP) right before conjugation if free thiols are required; do not store with reductants.
Quality and Grades
Item-specific grade/purity and appearance: Not specified for this item; refer to CoA/Spec Sheet.
Context for PEG-activated reagents (general information):
PEG linkers with NHS and thiol functionality are typically supplied at high chemical purity with low residual solvents and tightly controlled functionality (e.g., degree of substitution, residual acid/NHS). Exact specifications vary by lot and manufacturer.
Functional titer: For NHS esters, an active ester content or substitution level may be reported on the CoA (e.g., via hydroxylamine titration). Thiol content may be reported via Ellman’s assay. For this listing, such values are not specified; consult the CoA.
Stabilization and packaging: Often packaged under inert gas, in amber vials with desiccants, to minimize hydrolysis and oxidation. This item is indicated as Argon charged.
Analytical controls (typical for this class): NMR (1H/13C), FTIR (succinimide carbonyls), MS or GPC for PEG chain distribution, HPLC/UPLC for low-MW impurities, Karl Fischer for moisture. UV cutoffs and trace metals are generally not defining for these reagents.
Suitability: Research-grade material appropriate for method development, bioconjugation, surface modification, and materials research. For regulated applications, users should define internal acceptance criteria and may require additional testing and qualification.
Bottom line: For lot-specific quality details (purity, assay, residuals, functionality), rely on the CoA/Spec Sheet for SKU M163952.
Reaction and Applications
Manufacturer Application: Not specified beyond the product title; reagent is for research use only.
General applications for methoxy-PEG NHS/thiol linkers (informational, not product-specific claims):
Heterobifunctional conjugation: NHS ester(s) enable rapid amide bond formation with primary amines (e.g., lysine side chains, amine-functional surfaces). The thiol functionality (dithiol) supports Michael addition to maleimides, thiol–ene click chemistry, disulfide exchange, and gold–thiolate surface attachment.
Surface and material modification: Introduce PEGylated, antifouling layers on particles, polymers, or metal surfaces (Au, Ag) while forming covalent amide linkages to amine-bearing substrates.
Protein/biomolecule PEGylation (research): Create PEG–biomolecule conjugates to modulate solubility and reduce nonspecific interactions; select conditions to maintain bioactivity (avoid over-modification).
Nanobiotechnology: Link PEG chains between different functional domains (e.g., amine-bearing ligands on one side, maleimide-activated carriers on the other via thiol generation).
Practical tips:
NHS-amine coupling proceeds efficiently in pH 7.5–8.5 buffers; maintain low temperature and short exposure to aqueous media to limit hydrolysis.
Minimize headspace oxygen; prepare thiol-containing solutions immediately before use. If necessary, reduce disulfides in situ with TCEP (avoid DTT if maleimide coupling follows).
Control stoichiometry and time to avoid over-PEGylation in protein work. Quench unreacted NHS with ethanolamine or Tris only after the intended reaction is complete.
Reaction Conditions
Item-specific optimized conditions: Not specified for this item; refer to CoA/Spec Sheet. Below are general, literature-informed guidelines for NHS/thiol PEG reagents (not specifications):
NHS–amine coupling (general):
Solvent/buffer: anhydrous DMF or DMSO for stock; dilute into 50–100 mM bicarbonate (pH 8.3–8.6) or PBS/phosphate (pH 7.2–7.8).
Temperature/time: 0–25°C, 15 min to 2 h depending on substrate. Elevated temperatures accelerate hydrolysis and are generally avoided.
Stoichiometry: 1.1–5.0 equiv of NHS reagent per amine site; optimize to balance conversion and over-modification.
Additives: 1–5 mM EDTA; optionally triethylamine or DIPEA in non-aqueous couplings. Avoid amine buffers in aqueous couplings.
Thiol coupling (general):
Maleimide coupling: pH 6.5–7.2, 0–25°C, 15–120 min. Maintain argon/nitrogen blanket; include EDTA.
Thiol–ene click: photoinitiator (e.g., Irgacure 2959 for aqueous; DMPA for organic), UV 320–365 nm; minutes to tens of minutes depending on intensity and substrate.
Disulfide exchange: mild base (pH 7.5–8.5) with a defined redox couple when needed.
Workup and analysis:
Quench unreacted NHS with ethanolamine (non-aqueous) or adjust pH to neutral and remove small molecules by dialysis/SEC for bioconjugates.
Monitor progress via LC/MS (small molecules), SDS-PAGE or SEC (bioconjugates), Ellman’s assay for thiol content, and TNBS/OPA assays for residual amines.
Note: Hydrolysis half-life of NHS esters is strongly pH/temperature dependent; minimize aqueous exposure prior to reaction setup.
Safety and Handling
GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to the SDS for authoritative safety information.
General safety considerations for PEG-based NHS/thiol functional reagents (informational):
Hazards: NHS esters are irritants; thiols may cause skin/eye irritation and have strong odors. Dusts/particulates can irritate the respiratory tract. Not for human or animal use.
PPE: lab coat, nitrile gloves (double-glove for extended handling), safety glasses or splash goggles. Work in a fume hood, particularly when weighing powders or preparing solutions.
Incompatibilities: moisture (promotes NHS hydrolysis), strong bases (accelerate hydrolysis), oxidizers (promote thiol oxidation), and nucleophilic amine-containing buffers (e.g., Tris) that can consume NHS groups.
First aid (general):
Skin: wash with soap and water. Remove contaminated clothing.
Eyes: rinse cautiously with water for several minutes; remove contact lenses if present and easy.
Inhalation: move to fresh air; seek medical attention if symptoms persist.
Ingestion: rinse mouth; seek medical advice.
Special risks: thiols can oxidize to disulfides; limit air exposure. NHS esters can liberate NHS upon hydrolysis; maintain dry conditions until use. PEG materials may become slippery if spilled—use appropriate absorbents.
Waste: segregate organic solutions; avoid drain disposal. Deactivate residual NHS ester by controlled hydrolysis before disposal if required by local regulations.
Always consult the product’s SDS for definitive guidance.
Solvent Selection
Item-specific solvent requirements: Not specified for this item; refer to CoA/Spec Sheet.
General guidance for methoxy-PEG NHS/thiol reagents:
Polarity class: strongly polar, hydrogen-bond acceptor rich; typically miscible with polar aprotic solvents (DMF, DMSO, NMP, acetonitrile). Water miscibility increases with PEG length.
Recommended anhydrous solvents for stock solutions: DMF or DMSO (dry, oxygen-free). For immediate aqueous conjugations, dissolve in minimal dry DMF/DMSO, then dilute into buffer just before use.
Aqueous buffers for NHS-amine coupling: bicarbonate/carbonate (pH 8.0–9.0), phosphate or PBS (pH 7.2–7.8). Avoid primary amine-containing buffers (e.g., Tris, glycine) that compete with the intended amine target.
Thiol chemistry solvents/buffers:
Maleimide coupling: phosphate or HEPES at pH 6.5–7.5 (limits maleimide hydrolysis), optionally with 1–5 mM EDTA to chelate metal ions that catalyze thiol oxidation.
Radical thiol–ene: organic media (MeOH, MeCN, toluene/MeCN) or aqueous/organogel systems under photoinitiation.
Degassing/inerting: purge solutions with argon or nitrogen to minimize thiol oxidation; prepare immediately prior to use.
Quick comparison (general):
DMF: excellent solvating power; good for activated esters; dry grades readily available.
DMSO: very high polarity; mixes easily with aqueous buffers; higher viscosity may slow dispensing.
ACN: workable for some NHS esters but may have limited PEG solubility at higher MW.
Water/buffer: convenient for conjugation; use immediately due to NHS hydrolysis.
Storage Conditions: Store at −20°C, Argon charged.
Shipped In: Ice chest + Ice pads.
Research Use Note: For research use only.
General handling guidance for PEG NHS/thiol reagents:
Protect from moisture, oxygen, and light. Keep vial tightly sealed; allow to equilibrate to room temperature in a desiccator before opening to prevent condensation.
After opening, promptly prepare single-use aliquots under inert gas to minimize repeated freeze–thaw and headspace oxygen.
Reconstitution (general suggestions; not specifications):
Solvents: anhydrous DMSO or DMF under inert atmosphere. Typical stock concentrations: 10–100 mM depending on solubility; verify with a small test aliquot.
Aqueous use: add organic stock to degassed buffer immediately before reaction. Avoid amine-containing buffers for NHS chemistry.
Thiol integrity: if the reagent is supplied as free thiol, minimize air exposure; if disulfide-protected, reduce immediately prior to use (e.g., TCEP), then remove excess reductant if incompatible downstream.
Stability tips:
Avoid extended exposure above 0–4°C when in solution; prepare fresh solutions for each experiment.
Discard solutions showing signs of hydrolysis (loss of NHS signal by NMR/IR) or oxidation (decreased free thiol titer by Ellman’s assay).
For lot-specific stability, solubility limits, and reconstitution recommendations, consult the CoA/Spec Sheet for SKU M163952.
Structure and Identity
Item-specific identifiers (CAS, InChIKey, SMILES, molecular formula, exact molecular weight): Not specified for this item; refer to CoA/Spec Sheet.
What the name implies (general/literature context):
The term "Methoxy PEG dithiol NHS" suggests a polyethylene glycol (PEG) backbone that is terminated and/or functionalized with:
a methoxy group (–OCH3) on one terminus (typical for mPEG capping),
one or more thiol (–SH) groups ("dithiol") providing thiol reactivity (e.g., for maleimide coupling, thiol–ene, or disulfide chemistry), and
N-hydroxysuccinimide (NHS) activated ester functionality for rapid amide formation with primary amines.
The precise architecture (e.g., linear mPEG bearing a distal NHS-activated ester and a distal dithiol, vs. multiple NHS groups, spacer placement, PEG chain length) is not specified here and should be confirmed on the CoA/Spec Sheet.
Structural features (general PEG linker description):
Repeating –CH2–CH2–O– units forming a flexible, hydrophilic polymer chain.
Terminal methoxy capping reduces one-end reactivity and increases hydrophilicity/stealth.
NHS-activated ester(s) are typically adjacent to a carbonyl (–CO–O–NHS), enabling nucleophilic acyl substitution by amines.
Thiol groups (–SH) enable Michael addition to maleimides, radical thiol–ene, Au–S chemisorption, or disulfide exchange.
2D description in words (generic): a linear PEG chain with one terminus capped by methoxy and other terminus (or side arm) bearing an NHS-activated ester; additional thiol functionality (two –SH groups overall) located at termini or on side arms depending on specific design (not specified for this item).
Synthetic Utility
General synthetic value (informational):
Functional group set: NHS-activated ester(s) enabling amide formation with primary amines; dithiol enabling thiol-based ligations (Michael addition to maleimides, thiol–ene click, Au–S surface attachment, disulfide exchange). Methoxy-capped PEG confers hydrophilicity while limiting uncontrolled multi-functionalization.
Linker role: Serves as a heterobifunctional (or multifunctional) spacer to bridge amine-bearing substrates with thiol-reactive partners, introducing a defined hydrophilic spacer that can improve solubility and reduce steric hindrance.
Orthogonality: NHS chemistry (amine-selective, mildly basic pH) is generally orthogonal to thiol–maleimide coupling (near-neutral pH), enabling sequential conjugation strategies.
Materials chemistry: Facilitates PEGylation of polymers, nanoparticles, and surfaces; the dithiol motif permits robust immobilization on gold and the formation of crosslinked networks via disulfide or thiol–ene chemistry.
Retrosynthetic and practical considerations:
Control hydrolysis and oxidation: Execute NHS coupling first in dry or minimally aqueous media; then reveal/maintain thiols for the subsequent step under inert atmosphere.
Use protecting groups strategically if both NHS and thiol chemistries might interfere (e.g., temporary thiol protection as S–Ac or disulfide formation, then reduction).
Characterization: Monitor conversions by NMR (amide formation), LC/MS (small-molecule conjugates), SEC (bioconjugates), Ellman’s assay (free thiols), and TNBS or fluorescamine assays (residual primary amines on targets).
Target Specificity
Not applicable to this chemical reagent. This product is not an antibody, protein, or nucleic acid probe, and no target/epitope/isotype information is provided in the Product Data. Users should refer to Reaction & Applications and Synthetic Utility sections for guidance on compatible functional groups (amines and thiols/maleimides) rather than biological targets.
Foire aux questions
How should this product be stored?
Store at ?20 °C under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.